Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,455 signal articles · 146 in last 24h · 154,143 total before filter · latest 1h ago
146last 24h
875last 7d
147● bullish (7d)
96● bearish (7d)
214publishers
AllMacro211Earnings108M&A125Regulatory21Product21Analyst17
✕ clear all filtersticker: JPMSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Banco Macro (BASE:BMA) Stock Gets Fair Value Trim As Analysts Split On Momentum
Simply Wall St.3d agoneutral
Banco Macro (BASE:BMA) Stock Gets Fair Value Trim As Analysts Split On Momentum

The latest update on Banco Macro focuses on a shift in valuation signals, including a Street high price target of US$132 alongside a revised fair value estimate of ARS 17,588.77. This change sits within a split analyst backdrop, where some research points to potential upside, while others lean toward a more cautious stance on execution and momentum. As you read on, you will see how these price targets fit into the broader narrative and how to track the next moves in Banco Macro’s...

JPMorgan Sees Dealmaking On Track for Record Year
Bloomberg3d agoneutralVIDEO
JPMorgan Sees Dealmaking On Track for Record Year

Dorothee Blessing, Global Investment Banking Co-Head at JPMorgan, says it's been a busy year for dealmaking. She speaks exclusively with Menaka Doshi from the sidelines of the JPMorgan India Conference.

Investing.com4d agoneutral
Why Greek banks deserve your attention

Investing.com -- Greek banks have moved from a post-crisis balance-sheet repair story into one centred on growth, earnings and shareholder returns, with J.P. Morgan forecasting 12% annual EPS growth between 2025 and 2028 and mid-teens returns on tangible equity.

Bank of New York Mellon Corporation (BNY) Lost A Depositary Mandate
Simply Wall St.5d agoneutral
Bank of New York Mellon Corporation (BNY) Lost A Depositary Mandate

Bank of New York Mellon Corporation (NYSE:BNY) has been replaced as depositary for Kazia Therapeutics Limited’s American Depositary Receipt program. Kazia Therapeutics has appointed JPMorgan Chase Bank, N.A. as the new depositary for its ADRs, according to the company’s latest update. The shift away from Bank of New York Mellon Corporation in Kazia’s ADR program highlights a change in a visible client mandate for BNY’s capital markets services. The replacement of Bank of New York Mellon...

IREN (IREN) Stock Fair Value Edges Lower As AI Cloud Wins Meet Build Out Risks
Simply Wall St.6d agobullish
IREN (IREN) Stock Fair Value Edges Lower As AI Cloud Wins Meet Build Out Risks

The latest update on IREN trims the Fair Value estimate from US$80.93 to US$79.03, a relatively modest adjustment given the size of its AI ambitions. Analysts link this move to a mix of growing AI cloud contracts and ongoing questions around execution and supply build out through 2027, which both influence how comfortable they are with the stock’s valuation. As you read on, you will see how these shifting assumptions and fresh research calls are shaping the evolving IREN story and what it...

PG&E (PCG) Stock Fair Value Edges Lower As Analysts Split On Wildfire Risk
Simply Wall St.6d agoneutral
PG&E (PCG) Stock Fair Value Edges Lower As Analysts Split On Wildfire Risk

PG&E’s latest analyst update includes a trim to its fair value estimate, with the price target moving from US$20.78 to US$19.66. That shift reflects a split view on the stock, as some firms see opportunity after recent target resets, while others stay focused on wildfire policy risk, the revised capex plan, and the extended timeline for any reform in California. Read on to see what is driving these calls and how to follow the evolving PG&E story from here. Stay updated as the Fair Value for...

Sodexo (ENXTPA:SW) Stock Gets Fair Value Bump After Analyst Target Increases
Simply Wall St.6d agoneutral
Sodexo (ENXTPA:SW) Stock Gets Fair Value Bump After Analyst Target Increases

Sodexo’s fair value estimate has shifted from €52.66 to €54.63, a change of about 3.7% that fine tunes where analysts see the stock’s long term potential. This sits alongside a series of upward price target moves from more positive houses, even as others keep Neutral or Underweight ratings and cluster in the €50 to €60 range. As you read on, you will see how to track these changing targets and what they might mean for your own view on Sodexo. Analyst Price Targets don't always capture the...

JPMorgan Sees Investment Banking and Trading Powering Q3 Growth
Insider Monkey6d agoneutral
JPMorgan Sees Investment Banking and Trading Powering Q3 Growth

JPMorgan Chase & Co. (NYSE:JPM) expects investment banking fees and markets revenue to rise in the mid-to-high teens percentage in the third quarter, according to co-President Doug Petno, contrasting sharply with Bank of America’s expectation for a roughly 10% decline in investment banking fees. Petno said JPMorgan entered the quarter with a strong pipeline and […]

Stocks Bend, but Don’t Break, in Head-Spinning September. More Tests Are Coming.
Barrons.com6d agoneutral
Stocks Bend, but Don’t Break, in Head-Spinning September. More Tests Are Coming.

A massive surge in Treasury bond yields, which lifted 10-year notes to the highest since 2007, paired with a worrying summer rally in global crude prices that has oil trading firmly north of $100 a barrel, leaned heavily on stocks but didn’t tip them over. A Federal Reserve interest-rate hike, coupled with hawkish language and quickening inflation forecasts, also came and went, with stocks posting their strongest gains in six weeks and an index of the Magnificent Seven tech giants coming within half a point of the all-time high it reached in late May. Tech stocks, in fact, have largely weathered a series of “end of days” headlines from the AI space, with an index of semiconductor stocks falling around 3.3% over the past month and those in the information technology edging just 1.2% lower despite the torrent of stories tied to apocalyptic AI risks.

Charles River Laboratories International (CRL) Stock Fair Value Rises After Analysts Lift Targets
Simply Wall St.6d agoneutral
Charles River Laboratories International (CRL) Stock Fair Value Rises After Analysts Lift Targets

The analyst fair value estimate for Charles River Laboratories International has shifted from US$230.93 to US$282.43, a change of about 22% in the updated work. That move sits against Street commentary that now ranges from targets in the low US$200s to just above US$300. This reflects both renewed optimism around growth execution and ongoing discussion about valuation and timing. As you read on, you will see how this evolving price target story fits into the broader narrative and what signals...

JPMorgan Chase (JPM) Commits $750 Billion to Rebuilding America’s Housing Supply
Insider Monkey7d agoneutral
JPMorgan Chase (JPM) Commits $750 Billion to Rebuilding America’s Housing Supply

JPMorgan Chase & Co. (NYSE:JPM) said it plans to place more than $750 billion through 2035 to increase U.S. housing supply and support homeownership, with the Wall Street Journal covering the pledge as part of its broader American Dream Initiative. The commitment, nearly 40% more than the bank’s housing-related capital deployment over the prior decade, […]